Markets › India › NSE › ARISTO-SM

Aristo Bio-tech An

NSE:ARISTO-SMBasic Materials

——At close · Market cap —

🔔 Alert▶ Test a strategy

INR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Trend	YoY
Cash & cash equivalents	0.0	0.0	0.0	0.1	0.0	0.0		−38.9%
Cash & short-term investments	0.0	0.0	0.0	0.1	0.0	0.0		−38.9%
Receivables	0.3	0.3	0.4	0.6	0.6	0.5		−2.6%
Inventory	0.3	0.2	0.3	0.4	0.5	0.6		+33.5%
Total current assets	0.7	0.6	0.8	1.1	1.2	1.3		+12.4%
Property, plant & equipment	0.1	0.1	0.2	0.2	0.2	0.2		−1.3%
Goodwill & intangibles	0.0	0.0	0.0	0.0	0.0	0.0		−25.0%
Long-term investments	0.0	0.0	0.0	0.0	0.0	0.0		—
Total assets	0.8	0.8	1.0	1.3	1.4	1.6		+10.4%
Payables	0.4	0.4	0.4	0.7	0.8	0.7		−8.0%
Short-term debt	0.1	0.1	0.1	0.1	0.1	0.3		+95.3%
Total current liabilities	0.6	0.5	0.6	0.8	1.0	1.0		+7.8%
Long-term debt	0.1	0.1	0.1	0.1	0.1	0.1		−0.1%
Total debt	0.2	0.3	0.2	0.2	0.2	0.4		+62.0%
Net debt	0.2	0.2	0.2	0.2	0.2	0.3		+86.7%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0		—
Total liabilities	0.7	0.6	0.7	0.9	1.0	1.1		+7.2%
Total equity	0.1	0.1	0.3	0.3	0.4	0.4		+19.2%
Retained earnings	0.1	0.1	0.0	0.0	0.0	0.0		—

INR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

ARISTO-SM · Balance sheet · TradingHolo